NCT04618900

Brief Summary

Implant placement in the posterior part of the maxilla is frequently compromised or impossible due to atrophy of the alveolar process and pneumatisation of the maxillary sinus. Therefore, alveolar ridge augmentation is frequently necessary before or in conjunction with implant placement. The most commonly used method to augment the maxillary premolar and molar region involves the maxillary sinus floor augmentation applying the lateral window technique with a grafting material. However, the lateral window technique is associated with prolonged patient treatment time and increased morbidity. Thus, osteotome-mediated sinus floor elevation (OSFE) with or without the use of a grafting material has been advocated, when the residual bone height is more than 6 mm. OSFE involves preparation of implant site through the use of concave osteotomes and elevation of the maxillary sinus floor. The survival of suprastructure and implants after OSFE with or without the use of a grafting material has never been assessed in long-term randomized controlled trials. A long-term study concluded that OSFE with no grafting material is a predictable treatment modality. High short-term implant survival rates after OSFE with or without the use of a grafting material have been reported in systematic reviews. However, the amount of new bone formation after OSFE with the use of a grafting material is significantly higher compared to the use of no grafting material, as documented in a systematic review. Harvesting of autogenous bone graft is associated with risk of donor site morbidity and bone substitutes of natural transplants involves a risk of contamination, activation of host immune system and disease transmission as well as they can be refused by patients for religious reasons or because they are in contrast with chosen lifestyle. Therefore, the objective of the present study is to test the H0-hypothesis of no difference in the long-term implant treatment outcome after OSFE with Bio-Oss Collagen compared with the use of no grafting material. A total of 40 consecutively healthy patients with a missing posterior tooth in the maxilla will be allocated at random to OSFE with Bio-Oss Collagen or no grafting material and simultaneous implant placement. Clinical and/or radiographical evaluation using periapical radiographs and Cone Beam Computer Tomography (CBCT) will be performed preoperatively, immediate postoperatively, after abutment connection, after prosthetic rehabilitation, one year, three years and five years after loading to assess the long-term implant treatment outcome and the volumetric changes of the augmented area. The primary outcome will include survival of suprastructures, survival of implants, volumetric stability of the augmented area, peri-implant marginal bone level, oral health related quality of life, and complications related to the two treatment modalities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 22, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

November 2, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 6, 2020

Completed
Last Updated

November 6, 2020

Status Verified

November 1, 2020

Enrollment Period

4 months

First QC Date

November 2, 2020

Last Update Submit

November 2, 2020

Conditions

Keywords

Alveolar ridge augmentationMaxillary sinus floor elevationBone substitute

Outcome Measures

Primary Outcomes (1)

  • Survival of suprastructures and implants

    Loss of suprastructures and dental implants

    1-year

Secondary Outcomes (1)

  • Volumetric stability of the grafting material

    1-year

Study Arms (2)

Osteotome-mediated sinus floor elevation with Bio-Oss collagen

EXPERIMENTAL

Sinus floor elevation with a grafting material (Bio-Oss collagen)

Procedure: Sinus floor elevation with a grafting material

Osteotome-mediated sinus floor elevation with no grafting material

PLACEBO COMPARATOR

Sinus floor elevation with no grafting material

Procedure: Sinus floor elevation with a grafting material

Interventions

The use of grafting material for sinus floor elevation

Osteotome-mediated sinus floor elevation with Bio-Oss collagenOsteotome-mediated sinus floor elevation with no grafting material

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and females of ≥20 years of age.
  • Missing one posterior maxillary tooth (premolar or molar) for more than 4 months.
  • Residual vertical alveolar bone height of the maxillary alveolar process ≤ 6-10mm ≤.
  • Width of the alveolar maxillary process ≥6.5 mm.
  • Mandibular occluding teeth.
  • Should be able to speak and understand Danish.

You may not qualify if:

  • Medical contraindications to implant therapy e.g. recent myocardial infarction and cerebrovascular accident, recent valvular prosthesis surgery, immunosuppression, bleeding issues, active treatment of malignancy, drug abuse, psychiatric illness and intravenous bisphosphonate treatment.
  • Irradiated jaw bones (radiotherapy treatment).
  • Full mouth plaque score \>25%.
  • Progressive marginal periodontitis in the maxilla and mandible.
  • Acute infection in the area intended for implant placement.
  • Parafunction, bruxism, or clenching.
  • Psychiatric problems or unrealistic expectations.
  • Heavy tobacco use, define as \>10 cigarettes per day.
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aalborg University Hospital

Aalborg, North Denmark, 9000, Denmark

Location

Related Publications (1)

  • Starch-Jensen T, Bruun NH, Spin-Neto R. Endo-sinus bone gain following osteotome-mediated sinus floor elevation with Bio-Oss Collagen compared with no grafting material: a one-year single-blind randomized controlled trial. Int J Oral Maxillofac Surg. 2023 Nov;52(11):1205-1215. doi: 10.1016/j.ijom.2023.03.009. Epub 2023 Mar 29.

MeSH Terms

Conditions

Prosthesis FailureBone Diseases, MetabolicPatient Satisfaction

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Healthy patients in need of dental implant in the posterior part of the maxilla
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, DDS, PhD

Study Record Dates

First Submitted

November 2, 2020

First Posted

November 6, 2020

Study Start

November 22, 2019

Primary Completion

April 1, 2020

Study Completion

November 1, 2020

Last Updated

November 6, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

No individual participant data will be shared with other researchers

Locations